CORRIGENDUM

This article refers to:

Randomized controlled study on the use of multiple-dose activated charcoal in patients with supratherapeutic phenytoin levels

Randomized controlled study on the use of multiple-dose activated charcoal in patients with supratherapeutic phenytoin levels, Skinner CG, Chang AS, Matthews AS, Reedy SJ, Morgan BW. Clin Toxicol Volume 50, issue 8 (September 2012), pages 764–9.

There were several errors in Table 1. For the “Time to study completion” the following are the corrected times for the Control Group: patient 1 – 172 hours, patient 2 – 35.6 hours, patient 5 – 11.6 hours, patient 6 – 196 hours, and patient 8 – 113 hours. For the MDAC Group, patient 1 – 19.3 hours, patient 2 – 13.0 hours, and patient 3 – 32.7 hours. For “Last measured concentration (mg/L)”, the following are the corrected values: Control Group patient 5 – 24.0; MDAC Group patient 1 – 23.9; and MDAC Group patient 2 – 22.4.

The corrected table is given below.

Table 1. Patient demographics, times, and phenytoin levels.

Patient	Age (years)	Initial concentration (mg/L)	Peak concentration (mg/L)	Last measured concentration (mg/L)	Time to study completion (hours)
Control Group
1	22	47.6	47.6	27.0	172
2	63	35.8	39.7	28.1	35.6
3	68	43.4	43.4	21.3	46.6
4	55	32.0	32.0	23.9	26.4
5	49	36.9	36.9	24.0	11.6
6	53	45.6	46.2	24.4	196
7	51	40.2	40.2	22.1	26.2
8	46	37.5	39.5	19.9	113
MDAC* Group
1	52	39.6	39.6	23.9	19.3
2	54	32.5	32.5	22.4	13.0
3	49	34.8	37.4	20.5	32.7
4	59	35.6	35.6	22.4	33.0
5	44	33.6	33.6	20.0	25.2
6	44	40.0	40.0	24.9	17.5
7	61	33.6	33.6	19.1	13.0

*multidose activated charcoal.